Sign Up to like & get
recommendations!
1
Published in 2017 at "Journal of Controlled Release"
DOI: 10.1016/j.jconrel.2017.06.024
Abstract: Abstract The first developed secretory phospholipase A2 (sPLA2) sensitive liposomal cisplatin formulation (LiPlaCisĀ®) is currently undergoing clinical evaluation. In the present study we revisit and evaluate critical preclinical parameters important for the therapeutic potential and…
read more here.
Keywords:
spla2 sensitive;
use spla2;
revisiting use;
cancer ... See more keywords